Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Market Cap

Beacon Pharmaceuticals has a market cap or net worth of 31.65 billion as of September 13, 2024. Its market cap has decreased by -44.08% in one year.

• Market Cap: 31.65B
• Enterprise Value: 41.47B
• Revenue: 9.89B
• Ranking: n/a
• PE Ratio: 67.91
• Stock Price: 125.20

Market Cap Chart

Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 31.65B, an increase of 58.77%. That is a compound annual growth rate of 3.33%.

Market Cap History

Date	Market Cap	% Change
Sep 12, 2024	31.65B	-44.08%
Dec 28, 2023	56.60B	-14.34%
Dec 29, 2022	66.07B	17.50%
Dec 30, 2021	56.23B	210.46%
Dec 30, 2020	18.11B	74.61%
Dec 30, 2019	10.37B	177.16%